SciELO - Scientific Electronic Library Online

 
vol.61 issue1New legal framework for the eradication of falsified medicines: the new safety devicesInnovation in the development of melted cheese for slicing from fresh goat cheese author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Ars Pharmaceutica (Internet)

On-line version ISSN 2340-9894

Abstract

SOTOCA-MOMBLONA, José Miguel et al. Effectiveness of hepatitis C antiviral treatment in attended patients from the outpatient pharmacy consultation. Ars Pharm [online]. 2020, vol.61, n.1, pp.45-47.  Epub July 20, 2020. ISSN 2340-9894.  http://dx.doi.org/10.30827/ars.v61i1.11672.

Objective:

To determine the effectiveness of the treatment of chronic hepatitis C determined as the sustained viral response at 12 weeks (SVR12) after the end of treatment with direct-acting antiviral drugs (DAA) (glecaprevir/pibrentasvir, sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir and grazoprevir/elbasvir) in attended patients from the outpatient pharmacy consultation.

Method:

a retrospective study that includes patients attended by pharmacists who started treatment between December 1, 2017 and May 31, 2018. Demographic data, disease, adherence and treatment consultations were recorded (interactions, adverse effects and others).

Results:

Two hundred and five patients were included, with different hepatitis C genotypes, fibrosis states and morbidity levels. Effectiveness was 99.5%, similar to that of clinical trials.

Conclusions:

These results resemble those obtained in pharmacy consultations in the United States, operating for more than ten years.

Keywords : Pharmaceutical care; Hepatitis C; Effectiveness.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )